Life Science Compliance Update – Page 10 – Policy & Medicine

Avoiding the Patient Assistance Program Spotlight

Not All Discounts Are Equal: Evaluating When Discounts May Be Construed as Unlawful

Nursing Facilities & Kickbacks – Is the DOJ Shifting Away from Pharma?

Co-Payment & Deductible Waivers as Illegal Inducements

Planning for the Future – HHS OIG’s 2017 Work Plan

Sailing with a New Safe Harbor in Sight: The EU-U.S. Privacy Shield

Managing Medical Inquiries in an Era of Data Analytics

Maintaining Independence & Objectivity – OIG Releases New IRO Guidance

Feeling Needy: The Why, What and How of Needs Assessments

Old Weapons with A New Purpose – Using Antitrust Laws to Control Drug Pricing